Pacira | PCRX - Current Liabilities



Pacira reported $313.16M in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
Astellas Pharma JPY 1.11T 46.33B Jun/2025
Bristol-Myers Squibb USD 27.53B 3.46B Jun/2025
Ironwood Pharmaceuticals USD 39.15M 10.24M Dec/2024
J&J USD 56.9B 6.58B Mar/2025
Ligand Pharmaceuticals USD 64.73M 6.05M Jun/2025
Novo Nordisk 207.52B 28.6B Jun/2025
Pacira USD 313.16M 1.57M Jun/2025
Perrigo USD 1.13B 52.3M Jun/2025
Pfizer USD 37.73B 1.27B Jun/2025
Supernus Pharmaceuticals USD 286.36M 4.59M Jun/2025
Teva Pharmaceutical Industries USD 11.86B 704M Jun/2025
Xeris Pharmaceuticals USD 95.17M 5.27M Jun/2025
Zoetis USD 3.37B 19M Jun/2025